Clinical study site status. The Company has successfully launched four CSSs and is preparing to launch a fifth Canadian CSS later in the year. The Company is in advanced discussions to launch a number of U.S. based CSS, subject to the United States economy recovering from the COVID-19 pandemic. The U.S. based Trial Management Organization is supporting the of launch 4 to 5 CSSs in 4Q2020 with potential to commence Study II patient enrollment and treatment as early as 1Q2021.